Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Diarrhea-Predominant and Constipation-Predominant Irritable Bowel Syndrome: Current Prescription Drug Treatment Options
Emily V. Wechsler, Eric D. Shah
Drugs (2021) Vol. 81, Iss. 17, pp. 1953-1968
Closed Access | Times Cited: 10

Showing 10 citing articles:

Gut liver brain axis in diseases: the implications for therapeutic interventions
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 91
Constipation Caused by Anti-calcitonin Gene-Related Peptide Migraine Therapeutics Explained by Antagonism of Calcitonin Gene-Related Peptide’s Motor-Stimulating and Prosecretory Function in the Intestine
Peter Holzer, Ulrike Holzer‐Petsche
Frontiers in Physiology (2022) Vol. 12
Open Access | Times Cited: 56
Decoding Abdominal Pain in Constipation-predominant Irritable Bowel Syndrome and Functional Constipation: Mechanisms and Managements
Jingyuan Luo, Qianqian Xu, Shujun Xu, et al.
Current Gastroenterology Reports (2025) Vol. 27, Iss. 1
Open Access
Current and future pharmacotherapies for the management of constipation-predominant irritable bowel syndrome
Olga Biniszewska, Damian Jacenik, Aleksandra Tarasiuk, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 8, pp. 1039-1049
Closed Access | Times Cited: 2
Irritable Bowel Syndrome: Current Landscape of Diagnostic Guidelines and Therapeutic Strategies
Dareen Chuy, Ryan S.K. Wi, Micheal Tadros
Gastroenterology Insights (2024) Vol. 15, Iss. 3, pp. 786-809
Open Access | Times Cited: 2
Altered gut microbiota–host bile acid metabolism in IBS-D patients with liver depression and spleen deficiency pattern
Liqing Du, Zhaozhou Zhang, Lixiang Zhai, et al.
Chinese Medicine (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 5
All-Hydrocarbon Stapled Peptide Multifunctional Agonists at Opioid and Neuropeptide FF Receptors: Highly Potent, Long-Lasting Brain Permeant Analgesics with Diminished Side Effects
Mengna Zhang, Biao Xu, Ning Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 24, pp. 17138-17154
Closed Access | Times Cited: 1
Improving the Treatment Response of Patients with Irritable Bowel Syndrome: Implementing a Second-Generation Artificial Intelligence System for Overcoming Resistance
Anat Hershko‐Moshe, Y. Hasin, Anat Nevo-Shor, et al.
GastroHep (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 2
Altered Gut Microbiota-Host Bile Acid Metabolism in IBS-D Patients with Liver Depression and Spleen Deficiency Pattern
Liqing Du, Zhaozhou Zhang, Lixiang Zhai, et al.
Research Square (Research Square) (2023)
Open Access
Diagnose and treat constipation- or diarrhoea-predominant irritable bowel syndrome with confidence
Caroline Fenton, Connie Kang
Drugs & Therapy Perspectives (2022) Vol. 38, Iss. 4, pp. 171-176
Closed Access
Page 1

Scroll to top